Alnylam Pharmaceuticals, Inc. (ETR:DUL)
Germany · Delayed Price · Currency is EUR 294.40
-9.80 (-3.22%)
Jan 28, 2026, 5:35 PM CET
Alnylam Pharmaceuticals Market Cap
Alnylam Pharmaceuticals has a market cap or net worth of €39.15 billion as of January 28, 2026. Its market cap has increased by 30.54% in one year.
Market Cap
39.15B
Enterprise Value
39.19B
Revenue
2.74B
Ranking
n/a
PE Ratio
1,054.47
Stock Price
€294.40
Market Cap Chart
Since May 28, 2004, Alnylam Pharmaceuticals's market cap has increased from 94.86M to 39.15B, an increase of 41,175.27%. That is a compound annual growth rate of 32.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 27, 2026 | 39.15B | -12.50% |
| Dec 31, 2025 | 44.74B | 52.63% |
| Dec 31, 2024 | 29.32B | 34.90% |
| Dec 29, 2023 | 21.73B | -20.57% |
| Dec 30, 2022 | 27.36B | 53.40% |
| Dec 31, 2021 | 17.83B | 44.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Merck KGaA | 55.61B |
| Siemens Healthineers AG | 48.20B |
| Bayer Aktiengesellschaft | 45.91B |
| Fresenius SE & Co. KGaA | 27.90B |
| Sartorius Aktiengesellschaft | 15.68B |
| Fresenius Medical Care AG | 10.38B |
| Fielmann Group AG | 3.46B |
| Carl Zeiss Meditec AG | 2.42B |